S1P Therapeutics Inc.
Blacksburg, VA Doing business as Flux Therapeutics LLC
- UEI
- HC3CAHM3NQ68
- CAGE
- 86ZD1
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 501 Wildflower Ln, Blacksburg, VA 24060, USA
- Website
- s1ptx.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| SPNS2 inhibitors as renal fibrosis therapy - fibrosis is an aberrant wound healing process characterized by… | National Institute of Diabetes and Digestive and Kidney Diseases | $301,373 |
Quick answers
What is S1P Therapeutics Inc.'s UEI?
S1P Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is HC3CAHM3NQ68.
What is S1P Therapeutics Inc.'s CAGE code?
S1P Therapeutics Inc.'s CAGE code is 86ZD1.
What is S1P Therapeutics Inc.'s primary NAICS code?
S1P Therapeutics Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is S1P Therapeutics Inc. located?
S1P Therapeutics Inc.'s physical address in SAM.gov is 501 Wildflower Ln, Blacksburg, VA 24060, USA.
Is S1P Therapeutics Inc. registered in SAM.gov?
Yes. S1P Therapeutics Inc.'s SAM.gov registration is active through May 18, 2027.
What is S1P Therapeutics Inc.'s most recent federal award?
S1P Therapeutics Inc.'s most recent federal grant award is SPNS2 inhibitors as renal fibrosis therapy - fibrosis is an aberrant wound healing process characterized by… (R41DK136371), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 8, 2023.
On GovTribe
See S1P Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors